Background: Metabolic syndrome (MS) is considered a cause of abnormal deposition of fat into hepatocytes, which might be associated with hepatic steatosis or abnormal liver function. Objective: The aim of this study was to explore the factors associated with MS and the relationship between MS and abnormal aspartate aminotransferase (AST), alanine aminotransferase (ALT) and g-glutamyl transferase (GGT) levels in Taiwanese subjects without chronic hepatitis B (CHB) or C (CHC). Subjects: We enrolled 2539 Taiwanese adults without CHB or CHC (age range: 16-88 years old) and investigated the factors related to MS using the NCEP-ATP (National Cholesterol Education Program-Adult Treatment Panel) III criteria; body mass index (BMI) was measured using Asia-Pacific criteria. Results: The prevalence rate of MS in Taiwanese adults without CHB or CHC was 16.9% using the modified ATP III criteria and 15.4% using the International Diabetes Federation criteria. Males had a significantly higher prevalence rate than females (Po0.001), and subjects with MS were significantly older and had significantly higher BMI values and AST, ALT and GGT levels (all Po0.001). In univariate analyses, the abnormality of liver function test results were related to gender, level of fasting sugar, systolic blood pressure, triglyceride, high-density lipoprotein, BMI and MS (all Po0.05). Multivariate analysis showed that the male gender, a higher BMI value and MS were related to abnormal liver function test results. The cutoff value for ALT in relation to MS is 31 IU l À1 for male and 18 IU l À1 for female.
Introduction
Metabolic syndrome (MS) is an important public health syndrome because it is related to atherosclerosis, cardiovascular disease, the increasing mortality rate of cardiovascular disease and the development of type 2 diabetes. [1] [2] [3] [4] [5] [6] [7] [8] MS includes many cardiovascular risk factors, such as abdominal obesity, hypertension, hyperglycemia and dyslipidemia. 9, 10 As several different sets of criteria for diagnosing MS have been applied and study groups have differed, the reported prevalence rate of MS varies.
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As a relationship of MS to abnormal liver function test presentation has been reported in some studies, 12-15 a possible relationship between abnormal liver function test results and MS must also be considered. However, Miyatake et al. 12 used the MS criteria for Japanese to subjects without syndrome, Nannipieri et al. 14 selected subjects from a population-based diabetes survey, Wannamethee et al. 13 surveyed nondiabetic men aged 60-79 years and Hsiao et al. mentioned evaluating alanine aminotransferase (ALT) and hepatic fat content by ultrasound in patients with MS. In addition, the prevalence of MS in Taiwan varies in different populations and when applying different criteria. [16] [17] [18] As few studies as yet have focused on the relationship between MS and abnormal liver function in Taiwan, the aim of this study was to investigate the relationship between MS and other factors such as body mass index (BMI) with liver function tests, that is, aspartate aminotransferase (AST), ALT and g-glutamyl transferase (GGT), in Taiwanese adults without chronic hepatitis B (CHB) or C (CHC). Besides, we also evaluated the ratio of cutoff value for hepatic enzymes in relation to MS in Taiwan.
Subjects and methods

Patients
We retrospectively enrolled Taiwanese adults who had undergone regular health examinations in the Department of Preventive Medicine of Kaohsiung Municipal Hsiaokang Hospital and the Kaohsiung Medical University Hospital, Kaohsiung City in 2005. We excluded subjects who were positive for HBsAg (hepatitis B surface antigen) or had anti-HCV (antibodies to hepatitis C virus); with a known history of CHB or CHC; pregnant; with other severe systemic disease such as congestive heart failure with drug control or renal failure with or without dialysis; with severe hepatic or decompensated liver disease and taking medication with hepatotoxicity or consuming alcohol equal to or more than 40 g day
À1
. All of the subjects agreed to complete the questionnaires. Ultimately, 2539 subjects in total were enrolled in the study. This research was approved by the ethics committee of Kaohsiung Municipal Hsiaokang Hospital.
Data collection
Height, weight and waist circumference measurements for all of the subjects had been recorded on examination, and fasting sugar, fasting high-density lipoprotein-cholesterol (HDL-C) and triglyceride (TG), AST, ALT and GGT data had been collected after fasting for at least 12 h; these data were used in this study. BMI was calculated as weight per (height) 2 
(kg m À2
). Waist circumference was measured at the middle point between the upper point of the bilateral iliac crest and the inferior margin of the rib cage in the horizontal plane at the end of expiration while subjects stood with legs akimbo. Blood pressure (BP) was measured in the sitting position.
Blood samples were transported and sent for examination within 4 h. The following blood examinations were conducted using an automated system (TBA-200FR, Toshiba, Lab Medical, Tokyo, Japan): AST and ALT (UV without P5P activation), GGT (G-glutamyl-carboxy-nitroanilide method), GGT to predict the risk of MS using the modified NCEP-ATP III criteria and the IDF criteria for Asians by creating ROC (receiver operating characteristic) curves; we also analyzed the related sensitivity, specificity, positive predictive value, negative predictive and accuracy. Analyses were performed using the SPSS statistical package (SPSS Inc., Chicago, IL, USA).
Results
The basic characteristics of the study subjects are listed in Table 1 . A total of 2539 persons were enrolled in our study, the average age of whom was 43. , fasting glucose X110 or 100 mg per 100 ml or anti-diabetic drug treatment, TG X150 mg per 100 ml and waist circumference as compared with the female subjects (all Po0.001); in addition, the male participants had a significantly higher mean age, BP, BMI, waist circumference, AST, ALT and GGT than the female subjects (all Po0.001).
The prevalence rate of MS was found to be 16.9% using the modified NCEP-ATP III criteria and 15.4% using the IDF criteria in our study (Table 2 ). Significant differences were seen in gender, mean age, BMI, history of DM, history of hypertension, AST, ALT and GGT using both the modified NCEP-ATP III and the IDF criteria for Asians between subjects with and without MS (Po0.001).
Analyzing factors related to abnormal liver function (AST, ALT and GGT) (Table 3) , we found that gender, fasting sugar, systolic/diastolic BP, TG, HDL, mean waist circumference, BMI and MS (assessed using both the NCEP-ATP III and IDF criteria) were significantly different (Po0.001) between subjects with normal and abnormal liver function test results (Table 3) . History of DM was also found to be significantly associated with abnormal AST, ALT and GGT results (Po0.05), but history of hypertension was not significantly associated with an abnormal GGT result (P40.05).
Multivariate logistic analysis (Table 4) showed that an abnormal AST result was associated with being male, having MS (as assessed using both the modified NCEP-ATP III criteria and the IDF criteria for Asians) and having a higher BMI value, but younger age was only related to MS with modified NCEP-ATP III criteria. ALT result was associated with subjects being male, younger, having MS (as assessed using both the modified NCEP-ATP III criteria and the IDF criteria for Asians) and having a higher BMI value. GGT were related to being male, having MS (as assessed using both the modified NCEP-ATP III criteria and the IDF criteria for Asians) and having a higher BMI value (Table 4) . Table 5 shows the cutoff values used for AST, ALT and GGT to predict the risk of MS using the modified NCEP-ATP III criteria and the IDF criteria for Asians. Employing the modified NCEP-ATP III criteria, the cutoff values for AST, ALT and GGT were 29, 31 and 24 IU l À1 for males and 24, 18 and 14 IU l À1 for females, respectively. Using the IDF criteria for Asians, with the exception that the cutoff value for AST for males was 28 IU l À1 , the other cutoff values were the same as those used when employing the modified NCEP-ATP III criteria. Figure 1 shows Abbreviations: AST, aspartate aminotransferase; ALT, alanine aminotransferase; BMI, body mass index; GGT, g-glutamyl transferase. Liver function tests, metabolic syndrome and BMI M-H Hsieh et al the ROC curves, from which it can be seen that the percentiles for the cutoff values for AST, ALT and GGT were higher for the female subjects (Table 5) , and the largest area under ROC curve (AUC) was noted in GGT ( Figure 1 ).
Discussion
In our study, the rate of MS among Taiwanese adults was found to be 16.9% using the modified ATP III criteria and 15.4% using the IDF criteria. Males exhibited a significantly higher prevalence rate than females (Po0.001). MS was found to be significantly associated with higher mean age, higher BMI value and higher BP (Po0.001), in addition to metabolic factors. We also observed a significant association between MS and abnormal liver function test results among subjects without CHB or CHC.
The reported prevalence of MS in Taiwan varies according to the different MS criteria used and the study group. Lai et al. 17 conducted a hospital-based, cross-sectional study and showed that the prevalence rate of MS in old people was 44.1% using the ATI III criteria, and reported that the prevalence of MS was higher in women than in men (52.6 vs 35.8%, Po0.001). However, Hwang et al. 18 conducted a study of 5936 Taiwanese adults (2815 males), and found the prevalence rate of MS to be 15.7% using the modified ATP III criteria, 14.3% using the IDF criteria (Chinese version) and 16.4% using the metabolic criteria for Taiwanese, and reported that males with MS exhibited a higher prevalence rate. However, the prevalence of MS from study of Tsai et al., 16 which analyzed 867 subjects by modified NCEP-ATP III criteria, was higher (23.1%). The prevalence rate of MS found in our study was similar to that reported by Hwang et al., 18 and we therefore believe that males and older persons have a higher prevalence rate of MS in Taiwan. Previous studies have reported that MS, 12, 24, 25 higher BMI values and hyperlipidemia in subjects are associated with hepatic steatosis. 26, 27 Hepatic steatosis, even nonalcoholic steatohepatitis (NASH), is a liver disease that occurs in the absence of alcohol abuse and is frequently related to MS and type 2 diabetes. 12 We have previously reported that the severity of hepatic steatosis as assessed by ultrasound (B-mode, 3.5 MHz convex transducer) is significantly correlated with the results of hepatic enzyme tests such as AST, ALT and GGT (Po0.001); 15 however, whether hepatic steatosis can lead to abnormal hepatic enzyme test results remains controversial. [27] [28] [29] Regarding the relationship between MS and abnormal liver function, Miyatake et al.
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reported that AST, ALT and GGT are related to MS as defined by the new criteria published for use in Japanese subjects without CHB or CHC. Wannamethee et al. 13 reported that ALT and GGT are related to obesity, MS and IR, and Nannipieri et al. 14 reported that mild elevation in abnormal liver function is associated with features of MS identified in follow-up studies. In our study, MS was found to be significantly associated with higher AST, ALT and GGT Liver function tests, metabolic syndrome and BMI M-H Hsieh et al increased risk of liver disease-related death in Koreans. In our study, the largest values of sensitivity, specificity, positive predict value, negative predict value, accuracy and AUC were noted in GGT; the next two were ALT and AST, respectively. Therefore, we thought that GGT might be the most representative hepatic enzyme, which was related to MS, even though the accuracy of ALT and GGT was o80%. This result was similar to the study of Wannamethee et al., 13 which mentioned that ALT and GGT were strongly associated with MS. The cutoff values for ALT in relation to MS were set at 31 IU l À1 for males (percentiles for cutoff values ¼ 59.3%) and18 IU l À1 for females (percentiles for cutoff values ¼ 64.8%) in our study, and these results were similar to the study of Prati et al., 33 which mentioned that upper limits of ALT for men was 30 IU l À1 and for women was 19 IU l À1 in subjects with negative results on tests for HBsAg, anti-HCV, anti-HIV 1 and anti-HIV 2. Even though the accuracy of these cutoff values was about 57.22-77.95%, we thought that these values were worthy of reference in Taiwan, especially for females, and this issue should be evaluated in the future. Diabetes mellitus is considered an independent factor for NASH, 40 but the abnormal hepatic enzyme test results of the subjects in our study were found to be related to history of DM or hypertension in univariate analysis, except that history of hypertension was not related to GGT; some were related to MS, possible causes of which might be that subjects had taken drugs that controlled these diseases well, or that persons who met the criteria of MS did not all have hypertension. Hence, we suggest that evaluation of MS is more important than evaluation of hypertension history if subjects without CHB or CHC present with abnormal liver function test results, because BP was related to abnormal hepatic enzymes in our study. The male gender was also shown to be related to abnormal liver function test results. In our study, the male subjects exhibited significantly higher prevalence in most of the factors related to MS. In addition, being older was found to be associated with MS in our study, but in the analysis of liver function, multivariate analysis showed that being of a younger age was related to abnormal ALT levels. The possible cause of this result was not clear, and this issue should be further examined in the future.
The major limitation of this study was that we were unable to further evaluate the association between MS and hepatic steatosis because sonographic diagnoses and histological data were unavailable for the subjects included in the study. In addition, this cross-sectional study cannot provide follow-up results and examine the association of the condition of MS with abnormal liver function. Further studies are necessary to explore these issues.
In conclusion, the prevalence rate of MS in Taiwanese adults without CHB or CHC was found to be 16.9% using the modified ATP III criteria and 15.4% using the IDF criteria. Being male, having a higher BMI value and having MS were identified as being associated with abnormal liver function test results, including AST, ALT and GGT levels. In addition, we suggest that a suitable cutoff value for ALT in relation to MS is 31 IU l À1 for males and 18 IU l À1 for females, and ALT and GGT were more associated with MS than was AST.
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